60 Degrees Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SXTP and other ETFs, options, and stocks.

About SXTP

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. 

CEO
Geoffrey S. Dow
CEOGeoffrey S. Dow
Employees
3
Employees3
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
2010
Founded2010
Employees
3
Employees3

SXTP Key Statistics

Market cap
2.57M
Market cap2.57M
Price-Earnings ratio
-0.08
Price-Earnings ratio-0.08
Dividend yield
Dividend yield
Average volume
760.92K
Average volume760.92K
High today
$0.6771
High today$0.6771
Low today
$0.45
Low today$0.45
Open price
$0.4853
Open price$0.4853
Volume
3.29M
Volume3.29M
52 Week high
$6.00
52 Week high$6.00
52 Week low
$0.34
52 Week low$0.34

Stock Snapshot

60 Degrees Pharmaceuticals(SXTP) stock is priced at $0.59, giving the company a market capitalization of 2.57M. It carries a P/E multiple of -0.08.

As of 2026-01-19, 60 Degrees Pharmaceuticals(SXTP) stock has fluctuated between $0.45 and $0.68. The current price stands at $0.59, placing the stock +32.0% above today's low and -12.3% off the high.

The 60 Degrees Pharmaceuticals(SXTP)'s current trading volume is 3.29M, compared to an average daily volume of 760.92K.

In the last year, 60 Degrees Pharmaceuticals(SXTP) shares hit a 52-week high of $6.00 and a 52-week low of $0.34.

In the last year, 60 Degrees Pharmaceuticals(SXTP) shares hit a 52-week high of $6.00 and a 52-week low of $0.34.

People also own

Based on the portfolios of people who own SXTP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .